Vanguard Group Inc Cerus Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Vanguard Group Inc holds 10,721,323 shares of CERS stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,721,323
              Previous 10,553,236
              
        
           1.59%
        
      
          
        Holding current value
$15 Million
            Previous $14.7 Million
            
        
           3.06%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  17 transactions
	
  Others Institutions Holding CERS
# of Institutions
165Shares Held
139MCall Options Held
100KPut Options Held
16K- 
    
      Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.2MShares$26.9 Million0.22% of portfolio
- 
    
      Black Rock Inc. New York, NY13.9MShares$19.4 Million0.0% of portfolio
- 
    
      Baker Bros. Advisors LP New York, NY12.9MShares$18 Million0.18% of portfolio
- 
    
      Wasatch Advisors Inc Salt Lake City, UT8.53MShares$11.9 Million0.07% of portfolio
- 
    
      Nikko Asset Management Americas, Inc.6.06MShares$8.49 Million0.09% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $248M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...